ISR Immune System Regulation
ISR Holding: SARS-CoV-2 vaccine study approved by Bangladesh BMRC (Redeye)
2022-07-01 14:08
Redeye endorses ISR receiving approval from Bangladesh BMRC to conduct a clinical phase I/II study with the company’s COVID-19 vaccine.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se